A Case Report of Dyschromatosis Symmetrica Hereditaria with Glucose-6-Phosphate Dehydrogenase Deficiency

被引：0

作者：

Wang, Panpan ^{[1
]}

Tang, Chenyu ^{[1
]}

Zhao, Yige ^{[1
]}

Wang, Ping ^{[2
]}

机构：

[1] Zhejiang Chinese Med Univ, Hangzhou Peoples Hosp 3, Dept Dermatol, Hangzhou, Peoples R China

[2] Zhejiang Univ, Hangzhou Peoples Hosp 3, Dept Dermatol, Hangzhou Dermatol Hosp,Sch Med, Westlake Ave 38, Hangzhou, Peoples R China

来源：

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY | 2023年 / 16卷

关键词：

dyschromatosis symmetrica hereditaria; glucose-6-phosphate dehydrogenase deficiency; psychosis; ADAR1; MUTATIONS; GENE;

D O I：

10.2147/CCID.S407052

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Dyschromatosis symmetrica hereditaria (DSH) is a pigmented genetic skin disorder with an incompletely understood pathogenesis characterized by reticular hyper-and hypopigmented skin patches on the dorsal aspect of the extremities, freckle-like patches on the face, and unaffected palms and feet. There is no effective treatment available. Glucose-6-phosphate dehydrogenase (G6PD) deficiency has not been reported in the literature of DSH. We describe for the first time a case of DSH with G6PD deficiency and a family history of psychosis.

引用

页码：1047 / 1050

页数：4

共 16 条

[1]

Alshomar KM, 2021, INT J SURG CASE REP, V79, P73, DOI [10.1016/j.ijscr.2020.01.012, 10.1016/j.ijscr.2021.01.012]

[2] Gluclose-6-phosphate dehydrogenase deficiency [J].

Cappellini, M. D. ;

Fiorelli, G. .

LANCET, 2008, 371 (9606) :64-74

[3] Autosomal dominant ADAR c.3019G>A (p.(G1007R)) variant is an important mimic of hereditary spastic paraplegia and cerebral palsy [J].

Jones, Hannah F. ;

Stoll, Marion ;

Ho, Gladys ;

O'Neill, Dugald ;

Han, Velda X. ;

Paget, Simon ;

Stewart, Kirsty ;

Lewis, Jennifer ;

Kothur, Kavitha ;

Troedson, Christopher ;

Crow, Yanick J. ;

Dale, Russell C. ;

Mohammad, Shekeeb S. .

BRAIN & DEVELOPMENT, 2022, 44 (02) :153-160

[4] Patient with dyschromatosis symmetrica hereditaria treated with miniature punch grafting, followed by excimer light therapy [J].

Kawakami, Tamihiro ;

Otaguchi, Risako ;

Kyoya, Mikiko ;

Soma, Yoshinao ;

Suzuki, Tamio .

JOURNAL OF DERMATOLOGY, 2013, 40 (09) :771-772

[5] The E3 ubiquitin ligase SMURF2 stabilizes RNA editase ADAR1p110 and promotes its adenosine-to-inosine (A-to-I) editing function [J].

Koganti, Praveen ;

Kadali, Venkata Narasimha ;

Ayyathan, Dhanoop Manikoth ;

Emanuelli, Andrea ;

Paolini, Biagio ;

Levy-Cohen, Gal ;

Blank, Michael .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (05)

[6] Dyschromatosis symmetrica hereditaria may be successfully controlled by topical sunscreen [J].

Kono, Michihiro ;

Okamoto, Takashi ;

Takeichi, Takuya ;

Muro, Yoshinao ;

Akiyama, Masashi .

EUROPEAN JOURNAL OF DERMATOLOGY, 2018, 28 (06) :840-841

[7] Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria [J].

Miyamura, Y ;

Suzuki, T ;

Kono, M ;

Inagaki, K ;

Ito, S ;

Suzuki, N ;

Tomita, Y .

AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (03) :693-699

[8] Dyschromatosis symmetrica hereditaria with acral hypertrophy [J].

Murata, Teruasa ;

Yagi, Yosuke ;

Tanioka, Miki ;

Suzuki, Tamio ;

Miyachi, Yoshiki ;

Morita, Kazumasa ;

Utani, Atsushi .

EUROPEAN JOURNAL OF DERMATOLOGY, 2011, 21 (04) :649-650

[9] Dermoscopic features in a case of dyschromatosis symmetrica hereditaria [J].

Oiso, Naoki ;

Murata, Ichidai ;

Hayashi, Masahiro ;

Amatsu, Akinori ;

Yoshida, Masuki ;

Suzuki, Tamio ;

Kawada, Akira .

JOURNAL OF DERMATOLOGY, 2011, 38 (01) :91-93

[10]

Sheu HM, 1985, TAIWAN YI XUE HUI ZA, V84, P238

← 1 2 →